A women’s health technology company has received the FDA’s blessing to market deep learning-based software designed to help breast radiologists spot hard-to-find nascent cancers in 3D mammograms.
Hologic announced the win this week, saying its Genius AI cancer-detection product will supply stronger sensitivity than its predecessor while sharply reducing false positives.
The new software “delivers key metrics at the time of image acquisition to help radiologists categorize and prioritize cases by complexity and expected read time in order to optimize workflow and expedite patient care,” Hologic says.
The company adds that the new product is the only AI-powered offering in its market category that doesn’t require a dedicated server.
Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.